Does low-cost GIC have the same survival rate as high-viscosity GIC in atraumatic restorative treatments? A RCT

Marcoeli Silva de Moura1, Geovanna Peres de Sousa1, Maria Hellen Sâmia Fortes Brito1

  • 1Universidade Federal do Piauí - UFPI, Department of Pathology and Dental Clinics, Teresina, PI, Brazil.

Brazilian Oral Research
|January 30, 2020
PubMed

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
502
Types of Cement I01:21

Types of Cement I

Portland cement comes in several types, each with distinct properties and applications based on their chemical composition and hydration characteristics:
Type I (Ordinary Portland Cement) is widely used for general construction where special properties are not required. It has moderate sulfate resistance and heat of hydration.
Type II (Modified Cement) offers moderate resistance to sulfate attack and a lower rate of heat development compared to Type I. It is suitable for structures in...
298
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
138
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
517